Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH)

被引：0
|
作者：
Gamba, G. [1 ]
Montani, N. [1 ]
Trinchero, A. [1 ]
Pecci, A. [1 ]
Bertolino, G. P. [1 ]
Lodo, F. [1 ]
机构：
[1] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Internal Med, Haemophilia Ctr, I-27100 Pavia, Italy
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [31] A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
    BRAY, GL
    GOMPERTS, ED
    COURTER, S
    GRUPPO, R
    GORDON, EM
    MANCOJOHNSON, M
    SHAPIRO, A
    SCHEIBEL, E
    WHITE, G
    LEE, M
    GORDON, M
    BERTALONE, S
    LIPTON, R
    HILGARTNER, M
    ARKIN, S
    GILL, J
    KIM, H
    SHURIN, S
    SANTIAGOBORRERO, P
    ARKEL, YS
    KULKARNI, R
    GREENWOOD, MF
    RITCHEY, AK
    WERNER, E
    HAIRE, WD
    KISKER, T
    NEUFELD, E
    EWENSTEIN, B
    DEBIASI, R
    LAURIAN, Y
    KREUZ, W
    RODEGHIERO, F
    INGERSLEV, J
    GAZENGEL, C
    DIMICHELE, D
    COOPER, H
    BLOOD, 1994, 83 (09) : 2428 - 2435
  • [32] Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
    Abshire, T
    Kenet, G
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (06) : 899 - 909
  • [33] Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China
    Shi, J.
    Zhao, Y.
    Wu, J.
    Sun, J.
    Wang, L.
    Yang, R.
    HAEMOPHILIA, 2007, 13 (04) : 351 - 356
  • [34] Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A
    Wolf, DM
    Rokicka-Milewska, R
    Lopaciuk, S
    Skotnicki, AB
    Klukowska, A
    Laguna, P
    Windyga, J
    Kotitschke, R
    Struff, WG
    HAEMOPHILIA, 2004, 10 (05) : 438 - 448
  • [35] Efficacy and safety of factor eight inhibitor bypassing activity prophylaxis evaluation in young patients with hemophilia and high titer inhibitor
    Karimi, Mehran
    Tavoosi, Hakimeh
    Haghpanah, Sezaneh
    Ardeshiri, Resvan
    Zahedi, Zohreh
    Zarei, Tahereh
    Cohan, Nader
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (02) : 232 - 233
  • [36] Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor
    Stewart, AJ
    Hanley, JP
    Ludlam, CA
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 : S93 - S95
  • [37] Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome
    Agosti, Pasquale
    Siboni, Simona Maria
    Ciavarella, Alessandro
    Arcudi, Sara
    Boggio, Federico
    Gualtierotti, Roberta
    Peyvandi, Flora
    HAEMOPHILIA, 2024, 30 (02) : 336 - 344
  • [38] Clinical and laboratory data of safety, efficacy of a recombinant factor VIII concentrate in patients with severe haemophilia a in a private practice CCC
    KoehlerVajta, K.
    Froesner, G.
    Zachoval, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 220 - 221
  • [39] Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis
    Yin, Ellen B.
    Tan, Benedict
    Thuy Nguyen
    Salazar, Miguel
    Putney, Kimberly
    Gupta, Pramod
    Suarez, Jose I.
    Bershad, Eric M.
    NEUROCRITICAL CARE, 2017, 27 (01) : 51 - 59
  • [40] Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis
    Ellen B. Yin
    Benedict Tan
    Thuy Nguyen
    Miguel Salazar
    Kimberly Putney
    Pramod Gupta
    Jose I. Suarez
    Eric M. Bershad
    Neurocritical Care, 2017, 27 : 51 - 59
12345